INFLIXIMAB

214263 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking INFLIXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 39249
1 OFF LABEL USE 38111
2 CONDITION AGGRAVATED 19126
3 INFUSION RELATED REACTION 18853
4 PAIN 18332
5 RHEUMATOID ARTHRITIS 18283
6 ARTHRALGIA 17317
7 FATIGUE 16394
8 PRODUCT USE ISSUE 13296
9 RASH 13108
See all common reactions for INFLIXIMAB

INFLIXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 306 0.9162
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5577 0.8174
2 RED BLOOD CELL SEDIMENTATION RATE 218 0.7870
3 SWOLLEN JOINT COUNT INCREASED 2157 0.7309
4 PEMPHIGUS 8656 0.7247
5 RHEUMATOID FACTOR POSITIVE 4030 0.7209
6 RHEUMATIC FEVER 2959 0.7144
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 435 0.6651
8 GRANULOMA SKIN 529 0.6499
9 DUODENAL ULCER PERFORATION 4547 0.6498
See all enriched reactions for INFLIXIMAB